-69.3%
FCEL vs THC
+423.7%
-492.9%
-93.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -5.6% | -0.3% | -5.3% | -5.5% |
| 7D | -2.8% | +1.0% | -3.8% | -2.8% |
| 30D | -31.6% | +5.3% | -37.0% | -31.7% |
| 3M | -52.4% | +7.1% | -59.5% | -52.5% |
| 6M | -51.4% | +46.0% | -97.4% | -52.7% |
| YTD | +32.4% | +43.9% | -11.5% | +28.3% |
| 1Y | +37.5% | +45.4% | -7.9% | +32.5% |
| 3Y | -69.3% | +421.3% | -490.6% | -89.6% |
| All | -69.3% | +423.7% | -492.9% | -89.6% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling